ClinicalTrials.gg
RecruitingNCT04880096e-DOL cohortUpdated Nov 18, 2026

Cohort of Chronic Pain Patients

An observational study in Chronic Pain, sponsored by University Hospital, Clermont-Ferrand. Recruiting at 22 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University Hospital, Clermont-Ferrand · Observational

How we know

From the registry’s dates

  • Started Sep 2021; still recruiting 5 years 2 months later.
Updated Nov 18, 2026Results publication addedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 22 studies in Chronic Pain by University Hospital, Clermont-Ferrand — 5 open to participants now, 6 under way, none of them phase 3. Chronic Pain · University Hospital, Clermont-Ferrand.

Planned enrollment
Largest of 13
5,000 · median 501
Started
2021
with 1 other
Observational
13 of 22
2 open now
Registered
15th of 22
by date

Among the 22 studies in Chronic Pain by University Hospital, Clermont-Ferrand, this one has the largest planned enrollment of the 13 observational ones that give a count, is one of 2 that started in 2021, is one of 13 observational ones, and was the 15th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

5 of the 22 studies in Chronic Pain by University Hospital, Clermont-Ferrand are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Chronic Pain by University Hospital, Clermont-Ferrand, or all of them as a file.
02

Study summary

Chronic pain affects approximately 20% of adults, 50% of the elderly population and over 1.5 billion people worldwide. Societal and economic issues are also crucial, as 60% of people with pain are less able or unable to work and 20% say they have lost their jobs because of pain. The overall cost of chronic pain is estimated at around 300 billion euros in the EU. Unfortunately, current treatments for chronic pain have limited effectiveness and important adverse effects. Pain clinics, which support the most complex and refractory cases of chronic pain, as well as general practitioners and patients expect improvements, both in terms of therapeutic efficacy and organization of care.

In order to allow the characterization and a personalized follow-up of chronic pain patients, we have created e-DOL, a smartphone application for patients and a web platform for healthcare professionals in pain clinics. The purpose of this study is to create an e-cohort for the research, and characterization and follow-up of chronic pain patients.

Read the detailed description

This first French e-cohort of chronic pain patients will allow real-life follow-up in order to generate big data including various information on chronic pain, associated-comorbidities, pain impacts on sleep, activity and psycho-emotional parameters, sociodemographic characteristics and pain treatments.

These data will be collected with he eDOL tool (smartphone application for patients and web platform for caregivers in pain clinics), integrating numerous repeatable questionnaires, weekly barometers, a therapeutic education module and a conversational agent (chat bot).

All of these data will also be linked with French health insurance care data in order to get an overview of comorbidities and patient care consumption in a medico-economic approach.

The study will include 20 pain clinics and a minimum of 5000 patients followed for 24 months.

03

Conditions studied

  • Chronic Pain

Browse trials for

Keywords

  • Chronic Pain
  • e-Health
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patiant with chronic pain

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients with chronic pain
  • patients equipped and regular users of a smartphone
  • Non-opposition to participation in the study

Exclusion criteria

Exclusion Criteria:

  • Patient unable to understand or answer questionnaires
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • chronic pain patients

    All adult patients followed-up in participating pain clinics

    Other: eDOL

Interventions

  • OthereDOL

    e-health tool (mobile app for patients and web platform for caregivers in pain clinics)

06

What researchers measure

Primary outcomes

  1. multidimensional characterisation of chronic pain patients

    Multimodal exploratory analysis of the determinants and repercussions of chronic pain, and their evolution in a real-life context, taking into account all environmental events likely to influence chronic pain (treatments, history, co-morbidities, etc.).

    Time frame: 5 years

Secondary outcomes

  1. Multivariate descriptive analyses

    Study the relationships between the measured criteria

    Time frame: 5 years

  2. Longitudinal analyses

    Describe the distribution and temporal evolution of the measured variables

    Time frame: 5 years

07

Study locations

19 of 22 sites recruiting
08

References and documents

Publications

  • Delage N, Cantagrel N, Soriot-Thomas S, Frost M, Deleens R, Ginies P, Eschalier A, Corteval A, Laveyssiere A, Phalip J, Bertin C, Pereira B, Chenaf C, Doreau B, Authier N; ePAIN; Kerckhove N. Mobile Health App and Web Platform (eDOL) for Medical Follow-Up of Patients With Chronic Pain: Cohort Study Involving the French eDOL National Cohort After 1 Year. JMIR Mhealth Uhealth. 2024 Jun 12;12:e54579. doi: 10.2196/54579. PubMed 38865173 ↗
  • Kerckhove N, Soubeiga A, Phalip J, Bertin C, Doreau B, Moisset X, Delage N, Authier N, Antoine V, Pereira B. Digital Monitoring and Chronic Pain Trajectories in Patients Receiving Tertiary Pain Care. JAMA Netw Open. 2026 Aug 3;9(8):e2627217. doi: 10.1001/jamanetworkopen.2026.27217. PubMed 42550506 ↗
09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2021 (actual). Primary completion is estimated for Sep 2031, 120 months after the start.

Of 337 non-industry observational studies under Chronic Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 56. This study's planned 120 months is above that.

Counting every sponsor, half of 363 studies reached it within 24 months; a quarter within 12 and three quarters within 56.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: primary completion Sep 2026 → Sep 2031 and completion Sep 2026 → Sep 2031.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2021
First posted
May 10, 2021
StartActual
Sep 14, 2021
Primary completionEst.
Sep 14, 2031was Sep 2026
CompletionEst.
Sep 14, 2031was Sep 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 1, 2026→Sep 14, 2031
Oct 29, 2026
Study completion
Sep 1, 2026→Sep 14, 2031
Oct 29, 2026
Publications
Results publication added: Kerckhove N, Soubeiga A, Phalip J, Bertin C, Doreau B, Moisset X, Delage N, Authier N, Antoine V, Pereira B. Digital Monitoring and Chronic Pain Trajectories i… PubMed 42550506 ↗
Nov 18, 2026
Show all 2 updates
  1. Nov 18, 2026
    Publications Results publication added: Kerckhove N, Soubeiga A, Phalip J, Bertin C, Doreau B, Moisset X, Delage N, Authier N, Antoine V, Pereira B. Digital Monitoring and Chronic Pain Trajectories i… PubMed 42550506 ↗
  2. Oct 29, 2026
    Primary completion Sep 1, 2026→Sep 14, 2031
    Study completion Sep 1, 2026→Sep 14, 2031
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04880096
Collaborators
Institut ANALGESIA
Responsible party
Sponsor
First posted
May 10, 2021
Start date
Sep 14, 2021
Primary completion
Sep 14, 2031 (estimated)
Completion
Sep 14, 2031 (estimated)
Last update
Nov 18, 2026

Study contacts

Lise Laclautre
Contact
promo_interne_drci@chu-clermontferrand.fr
04 73 75 11 95

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion